183 related articles for article (PubMed ID: 33442023)
21. A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma.
Farley MN; Schmidt LS; Mester JL; Pena-Llopis S; Pavia-Jimenez A; Christie A; Vocke CD; Ricketts CJ; Peterson J; Middelton L; Kinch L; Grishin N; Merino MJ; Metwalli AR; Xing C; Xie XJ; Dahia PLM; Eng C; Linehan WM; Brugarolas J
Mol Cancer Res; 2013 Sep; 11(9):1061-1071. PubMed ID: 23709298
[TBL] [Abstract][Full Text] [Related]
22. Pathogenic ATM and BAP1 germline mutations in a case of early-onset, familial sarcomatoid renal cancer.
Bell HN; Kumar-Sinha C; Mannan R; Zakalik D; Zhang Y; Mehra R; Jagtap D; Dhanasekaran SM; Vaishampayan U
Cold Spring Harb Mol Case Stud; 2022 Apr; 8(3):. PubMed ID: 35483881
[TBL] [Abstract][Full Text] [Related]
23. Germline SDHB mutations and familial renal cell carcinoma.
Ricketts C; Woodward ER; Killick P; Morris MR; Astuti D; Latif F; Maher ER
J Natl Cancer Inst; 2008 Sep; 100(17):1260-2. PubMed ID: 18728283
[TBL] [Abstract][Full Text] [Related]
24. Genomic profiles of renal cell carcinoma in a small Chinese cohort.
Tai S; Xu DD; Yu Z; Guan Y; Yin S; Xiao J; Xue S; Liang C
Front Oncol; 2023; 13():1095775. PubMed ID: 37427096
[TBL] [Abstract][Full Text] [Related]
25. 8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness.
Eckel-Passow JE; Yan H; Kosel ML; Serie D; Decker PA; Jenkins RB; Costello B; Leibovich B; Ho TH; Parker A
BMC Urol; 2020 Oct; 20(1):173. PubMed ID: 33121461
[TBL] [Abstract][Full Text] [Related]
26. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
Shu X; Gu J; Huang M; Tannir NM; Matin SF; Karam JA; Wood CG; Wu X; Ye Y
Carcinogenesis; 2018 May; 39(6):752-757. PubMed ID: 29635281
[TBL] [Abstract][Full Text] [Related]
27. No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome.
Vahteristo P; Koski TA; Näätsaari L; Kiuru M; Karhu A; Herva R; Sallinen SL; Vierimaa O; Björck E; Richard S; Gardie B; Bessis D; Van Glabeke E; Blanco I; Houlston R; Senter L; Hietala M; Aittomäki K; Aaltonen LA; Launonen V; Lehtonen R
Fam Cancer; 2010 Jun; 9(2):245-51. PubMed ID: 20091131
[TBL] [Abstract][Full Text] [Related]
28. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
29. Germline Whole-Gene Deletion of FH Diagnosed from Tumor Profiling.
Ueki A; Sugano K; Misu K; Aimono E; Nakamura K; Tanishima S; Tanaka N; Mikami S; Hirasawa A; Ando M; Yoshida T; Oya M; Nishihara H; Kosaki K
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360727
[TBL] [Abstract][Full Text] [Related]
30. Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma.
Kong W; Yang T; Wen X; Mu Z; Zhao C; Han S; Tian J; Zhang X; Zhou T; Zhang Y; Lou F; Cao S; Wang H; Zhang J
Front Oncol; 2021; 11():737547. PubMed ID: 34926252
[TBL] [Abstract][Full Text] [Related]
31. Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome.
Mester JL; Zhou M; Prescott N; Eng C
Urology; 2012 May; 79(5):1187.e1-7. PubMed ID: 22381246
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
33. A germline mutation in PBRM1 predisposes to renal cell carcinoma.
Benusiglio PR; Couvé S; Gilbert-Dussardier B; Deveaux S; Le Jeune H; Da Costa M; Fromont G; Memeteau F; Yacoub M; Coupier I; Leroux D; Méjean A; Escudier B; Giraud S; Gimenez-Roqueplo AP; Blondel C; Frouin E; Teh BT; Ferlicot S; Bressac-de Paillerets B; Richard S; Gad S
J Med Genet; 2015 Jun; 52(6):426-30. PubMed ID: 25911086
[TBL] [Abstract][Full Text] [Related]
34. Germline mutation in the NBR1 gene involved in autophagy detected in a family with renal tumors.
Adolphe F; Ferlicot S; Verkarre V; Posseme K; Couvé S; Garnier P; Droin N; Deloger M; Job B; Giraud S; Paillerets BB; Gardie B; Richard S; Renaud F; Gad S
Cancer Genet; 2021 Nov; 258-259():51-56. PubMed ID: 34488032
[TBL] [Abstract][Full Text] [Related]
35. DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy.
Ged Y; Chaim JL; DiNatale RG; Knezevic A; Kotecha RR; Carlo MI; Lee CH; Foster A; Feldman DR; Teo MY; Iyer G; Chan T; Patil S; Motzer RJ; Hakimi AA; Voss MH
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32571992
[TBL] [Abstract][Full Text] [Related]
36. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
37. Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management.
Shuch B; Vourganti S; Ricketts CJ; Middleton L; Peterson J; Merino MJ; Metwalli AR; Srinivasan R; Linehan WM
J Clin Oncol; 2014 Feb; 32(5):431-7. PubMed ID: 24378414
[TBL] [Abstract][Full Text] [Related]
38. [Development of human renal cell carcinoma (RCC)--the responsible genes for the development of hereditary and sporadic human RCCs].
Shuin T; Kamata M; Ashida S
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1719-25. PubMed ID: 12402420
[TBL] [Abstract][Full Text] [Related]
39. VHL gene alterations in Italian patients with isolated renal cell carcinomas.
Muscarella LA; D'Agruma L; la Torre A; Gigante M; Coco M; Parrella P; Battaglia M; Carrieri G; Carella M; Zelante L; Fazio VM; Gesualdo L; Ranieri E
Int J Biol Markers; 2013 Jun; 28(2):208-15. PubMed ID: 23558940
[TBL] [Abstract][Full Text] [Related]
40. Renal Cell Carcinoma with Clear Cell Papillary Features: Perspectives of a Differential Diagnosis.
Somorácz Á; Kuthi L; Micsik T; Jenei A; Hajdu A; Vrabély B; Rásó E; Sápi Z; Bajory Z; Kulka J; Iványi B
Pathol Oncol Res; 2020 Jul; 26(3):1767-1776. PubMed ID: 31656019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
